Sri Lanka vs United States of America: Proportion of isolates with resistance to azithromycin reported to
Sri Lanka
4.17
in 2018
United States of America
5.8
in 2020
Sri Lanka rank
28th
United States of America rank
26th
Proportion of isolates with resistance to azithromycin reported to over time
- Sri Lanka
- United States of America
How they compare
United States of America currently reports 5.8 against 4.17 in Sri Lanka, a difference of 1.63.
That makes United States of America's figure about 1.4 times Sri Lanka's.
The two have swapped places 2 times across 7 shared years of data; in 2011 it was United States of America ahead.
Sri Lanka ranks 28th and United States of America ranks 26th of 47 countries.
United States of America has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher proportion of isolates with resistance to azithromycin reported to, Sri Lanka or United States of America?
- United States of America, at 5.8 against 4.17 in Sri Lanka as of 2020.
- What is the difference in proportion of isolates with resistance to azithromycin reported to between Sri Lanka and United States of America?
- 1.63, with United States of America ahead.
- How many years of comparable data are there for Sri Lanka and United States of America?
- 7 years are reported by both, from 2011 to 2018.
- How do Sri Lanka and United States of America rank globally for proportion of isolates with resistance to azithromycin reported to?
- Sri Lanka ranks 28th and United States of America ranks 26th of 47 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.